Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells

作者: Elena Daveri , Giuseppe Valacchi , Roberta Romagnoli , Emilia Maellaro , Emanuela Maioli

DOI: 10.1155/2015/545838

关键词: Cell growthPhosphorylationCyclin D1BioinformaticsMedicineDownregulation and upregulationRottlerinCancer researchProtein kinase BMAPK/ERK pathwaySignal transduction

摘要: Melanoma is the most aggressive and chemoresistant form of skin cancer. Mutated, constitutively active B-RAF believed to play a crucial role, although selective inhibition has shown poor clinical success, since phenomena resistance usually occur, likely arising from additional genetic aberrations, such as loss function p53 PTEN, overexpression cyclin D1, hyperactivation NF-κB, downregulation p21/Cip1. Since all them are present in Sk-Mel-28 melanoma cells, this cell line could be an ideal, albeit hard study, model develop new therapeutic strategies. In current we tested cytostatic action Rottlerin on basis known effects main proliferative signaling pathways. We presented evidence that drug inhibits growth by Akt- p21/Cip1-independent mechanism, involving dual ERK NF-κB D1. addition, found increases phosphorylation, but, surprisingly, resulted decreased activity. Pull-down experiments, using Rottlerin-CNBr-conjugated Sepharose beads, revealed binds ERK, independently its phosphorylation status. This direct interaction part explain paradoxical blockage downstream arrest. would like dedicate paper memory our friend colleague, prematurely deceased, Claudia Torricelli, who actively contributed project.

参考文章(42)
Yukiko Ueda, Ann Richmond, NF‐κB activation in melanoma Pigment Cell Research. ,vol. 19, pp. 112- 124 ,(2006) , 10.1111/J.1600-0749.2006.00304.X
Osman Nidai Ozes, Lindsey D Mayo, Jason A Gustin, Susan R Pfeffer, Lawrence M Pfeffer, David B Donner, None, NF-κB activation by tumour necrosis factor requires the Akt serine–threonine kinase Nature. ,vol. 401, pp. 82- 85 ,(1999) , 10.1038/43466
Sarah-Jane Cozzi, Peter G. Parsons, Steven M. Ogbourne, Julie Pedley, Glen M. Boyle, Induction of Senescence in Diterpene Ester–Treated Melanoma Cells via Protein Kinase C–Dependent Hyperactivation of the Mitogen-Activated Protein Kinase Pathway Cancer Research. ,vol. 66, pp. 10083- 10091 ,(2006) , 10.1158/0008-5472.CAN-06-0348
Jian-Feng Liu, Michel Crépin, Jian-Miao Liu, Denis Barritault, Dominique Ledoux, FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochemical and Biophysical Research Communications. ,vol. 293, pp. 1174- 1182 ,(2002) , 10.1016/S0006-291X(02)00350-9
GUOFANG ZENG, JIE LIU, HEGE CHEN, BIN LIU, QINGYU ZHANG, MINGYI LI, RUNZHI ZHU, Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells. Oncology Reports. ,vol. 31, pp. 2713- 2719 ,(2014) , 10.3892/OR.2014.3160
Minzhao Huang, Su-Ni Tang, Ghanshyam Upadhyay, Justin L Marsh, Christopher P Jackman, Rakesh K Srivastava, Sharmila Shankar, None, Rottlerin suppresses growth of human pancreatic tumors in nude mice, and pancreatic cancer cells isolated from Kras(G12D) mice. Cancer Letters. ,vol. 353, pp. 32- 40 ,(2014) , 10.1016/J.CANLET.2014.06.021
E. Maioli, C. Torricelli, G. Valacchi, Rottlerin and cancer: novel evidence and mechanisms. The Scientific World Journal. ,vol. 2012, pp. 350826- 350826 ,(2012) , 10.1100/2012/350826
Heng Wu, Vikas Goel, Frank G Haluska, PTEN signaling pathways in melanoma Oncogene. ,vol. 22, pp. 3113- 3122 ,(2003) , 10.1038/SJ.ONC.1206451
C. Torricelli, V. Fortino, E. Capurro, G. Valacchi, A. Pacini, M. Muscettola, K. Soucek, E. Maioli, Rottlerin inhibits the nuclear factor κB/Cyclin-D1 cascade in MCF-7 breast cancer cells Life Sciences. ,vol. 82, pp. 638- 643 ,(2008) , 10.1016/J.LFS.2007.12.020